Yasuhiro Nakamura

34PUBLICATIONS
178CO-AUTHORS
NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 07, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|May 25, 2026
Adjuvant treatment for acral melanoma.

|Mar 25, 2026
Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022.

Yoshiaki Kinoshita, Kosuke Ishikawa, Sadanori Akita

|Feb 17, 2026
Response to comment on 'Adj-PD-1 antibody vs. observation for resected nail apparatus melanoma'.

Takaya Komori, Yasuhiro Nakamura

|Jan 05, 2026
Efficacy of adjuvant anti-PD-1 antibody versus observation for resected nail apparatus melanoma.

Takaya Komori, Eiji Nakano, Yukiko Kiniwa

|Dec 04, 2025
Prognostic outcomes of immediate complete lymph node dissection versus observation in patients with acral melanoma of the sole with sentinel node metastasis: a retrospective, multicenter study.

Sadao Inoue, Shigeru Koizumi, Naoya Yamazaki

Pageof 6

Frequent Collaborators

10 joint publications

Takaya Komori

8 joint publications

Shigeru Koizumi

7 joint publications

Shigeto Matsushita

6 joint publications

Yoshiyuki Nakamura